Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 May 28:10:318.
doi: 10.3389/fendo.2019.00318. eCollection 2019.

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support

Silvia De Padova  1 , Chiara Casadei  2 , Alejandra Berardi  1 , Tatiana Bertelli  1 , Alessia Filograna  2 , Maria Concetta Cursano  3 , Cecilia Menna  2 , Salvatore Luca Burgio  2 , Amelia Altavilla  2 , Giuseppe Schepisi  2 , Sabrina Prati  2 , Sandra Montalti  2 , Michal Chovanec  3   4 , Giuseppe Luigi Banna  5 , Luigi Grassi  6 , Michal Mego  3   4 , Ugo De Giorgi  2
Affiliations
Review

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support

Silvia De Padova et al. Front Endocrinol (Lausanne). .

Abstract

Testicular cancer is the most common tumor in young males aged 15-40 years. The overall cure rate for men with testicular cancer is >90%, so a huge number of these patients will become testicular cancer survivors. These people may feel some stress in the experience of diagnosis, treatment, and consequences that affects the quality of life, and during follow-up, especially when new issues and emotional distresses appear over time, such as late side-effects of treatments and emotional challenges including fear of tumor relapse, fertility and sexuality concerns, and social and workplace issues. The cancer experience has an impact not only on patients, but also on their relatives (e.g., spouses, parents, or siblings), who often have to assume a caregiving role for the duration of and following treatment for cancer. Moreover, the caregiver plays an important role in supporting a man with a testicular cancer, providing physical and emotional care. This review presents a summary of existing knowledge regarding the impact and the burden of testicular cancer on caregivers.

Keywords: cancer; caregiver; long-term survivors; patients; testicular.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Factors influencing Caregiver emotional burden in TC patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, et al. . Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol. (2008) 19:259–64. 10.1093/annonc/mdm472 - DOI - PubMed
    1. De Giorgi U, Demirer T, Wandt H, Taverna C, Siegert W, Bornhauser M, et al. . Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience. Ann Oncol. (2005) 16:146–51. 10.1093/annonc/mdi017 - DOI - PubMed
    1. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, et al. . Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. (2005) 23:6549–55. 10.1200/JCO.2005.19.638 - DOI - PubMed
    1. Oing C, Seidel C, Bokemeyer C. Therapeutic approaches for refractory germ cell cancer. Expert Rev Anticancer Ther. (2018) 18:389–97. 10.1080/14737140.2018.1450630 - DOI - PubMed
    1. De Giorgi U, Rosti G, Aieta M, Testore F, Burattini L, Fornarini G, et al. . Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor. Eur Urol. (2006) 50:1032–8. 10.1016/j.eururo.2006.05.011 - DOI - PubMed

LinkOut - more resources